28.67USD-3.73%Mkt Cap: 1.65B USDP/E: —Last update: 2026-06-01
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.65B USD
Enterprise Value1.47B USD
Revenue (TTM)—
Gross Profit-92.92M USD
Net Income (TTM)-105.04M USD
Revenue/Share—
Last Price28.67 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees231
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS14070B3096
Valuation
P/E (Trailing)—
P/E (Forward)-39.23
PEG0.38
EV/EBITDA-12.48
EV/Revenue—
P/S—
P/B6.20
EPS (TTM)-2.32
EPS (Forward)-0.76
52W Range
4.30068% of range40.37
52W High40.37 USD
52W Low4.300 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-34.35%
ROA-29.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-69.81M USD
CapEx (TTM)11.72M USD
FCF Margin—
FCF Yield-4.26%
Net Debt-263.83M USD
Net Debt/EBITDA2.24
Balance Sheet
Debt/Equity0.05
Current Ratio8.42
Quick Ratio8.28
Book Value/Sh4.833 USD
Cash/Share4.811 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 5, 2019
Splits
Last Split1:10
Split DateJun 5, 2019
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)54.11 USD
Target Range38.00 USD – 63.00 USD
# Analysts9
Ownership
Shares Out.57.91M
Float48.55M
Insiders9.47%
Institutions59.70%
Short Interest
Short Ratio10.1d
Short % Float20.82%
Short % Out.18.85%
Shares Short10.92M
Short (prev mo.)10.04M
Technical
SMA 5031.56 (-9.2%)
SMA 20019.89 (+44.1%)
Beta0.48
S&P 52W Chg27.94%
Avg Vol (30d)968.32K
Avg Vol (10d)810.67K
Technical Indicators
RSI (14)47.0
MACD-0.8963
MACD Signal-0.8494
MACD Hist.-0.0469
BB Upper34.49 USD
BB Middle30.39 USD
BB Lower26.29 USD
BB Width26.97%
ATR (14)1.737 USD
Vol Ratio (20d)0.39x